Full List of Protein(s) Regulating This Metabolite |
Divalent anion:Na symporter (DASS) |
Solute carrier family 13 member 2 (SLC13A2) |
Click to Show/Hide the Full List of Regulating Pair(s): 5 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Mutation (T86C) of SLC13A2 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (T86C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Mutation (Y228C) of SLC13A2 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (Y228C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. |
Regulating Pair (3) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Mutation (Y432C) of SLC13A2 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (Y432C) of SLC13A2 leads to the decrease of oxoglutaric acid levels compared with control group. |
Regulating Pair (4) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Mutation (M539C) of SLC13A2 |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (M539C) of SLC13A2 leads to the increase of oxoglutaric acid levels compared with control group. |
Regulating Pair (5) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Mutation (N525C) of SLC13A2 |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (N525C) of SLC13A2 leads to the increase of oxoglutaric acid levels compared with control group. |
Solute carrier family 13 member 3 (SLC13A3) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Mutation (Ala254Asp) of SLC13A3 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (Ala254Asp) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Mutation (Gly548Ser) of SLC13A3 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that mutation (Gly548Ser) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. |
GPCR secretin (GPCR-2) |
Glucagon receptor (GCGR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Knockout of Gcgr |
Induced Change |
Oxoglutaric acid concentration: increase (FC = 2.3) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Type 2 diabetes mellitus [ICD-11: 5A11]
|
Details |
It is reported that knockout of GCGR leads to the increase of oxoglutaric acid levels compared with control group. |
Hydrolases (EC 3) |
Leukotriene-C4 hydrolase (GGT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Knockdown (siRNA) of GGT1 |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Renal cell carcinoma [ICD-11: 2C90]
|
Details |
It is reported that knockdown of GGT1 leads to the increase of oxoglutaric acid levels compared with control group. |
Phosphoinositide lipid phosphatase (PLIP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Knockout of Ptpmt1 |
Induced Change |
Oxoglutaric acid concentration: decrease (FC= 0.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Ptpmt1 leads to the decrease of oxoglutaric acid levels compared with control group. |
Mitochondrial carrier (MC) |
Solute carrier family 25 member 21 (SLC25A21) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Mutation (Lys232Arg) of SLC25A21 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Muscular atrophy [ICD-11: 8B61]
|
Details |
It is reported that mutation (Lys232Arg) of SLC25A21 leads to the decrease of oxoglutaric acid levels compared with control group. |
Organic ion transporter (OIT) |
Solute carrier family 22 member 7 (SLC22A7) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Overexpression of SLC22A7 |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that overexpression of SLC22A7 leads to the increase of oxoglutaric acid levels compared with control group. |
Oxidoreductases (EC 1) |
Alpha-ketoglutarate dehydrogenase (OGDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Knockout of OGDH |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
|
Details |
It is reported that knockout of OGDH leads to the increase of oxoglutaric acid levels compared with control group. |
Formyltetrahydrofolate dehydrogenase (ALDH1L2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[11] |
Introduced Variation |
Mutation of ALDH1L2 |
Induced Change |
Oxoglutaric acid concentration: increase (FC = 2.78) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Genetic disorders of keratinisation [ICD-11: EC20]
|
Details |
It is reported that mutation (patients) of ALDH1L2 leads to the increase of oxoglutaric acid levels compared with control group. |
Green heme-binding protein (FLR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Knockout of BLVRB |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of BLVRB leads to the decrease of oxoglutaric acid levels compared with control group. |
L-lactate dehydrogenase C chain (LDHC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[13] |
Introduced Variation |
Knockout of Ldhc |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Ldhc leads to the increase of oxoglutaric acid levels compared with control group. |
Oxalosuccinate decarboxylase (IDH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[14] |
Introduced Variation |
Mutation (R132H) of IDH1 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Brain cancer [ICD-11: 2A00]
|
Details |
It is reported that R132H mutation of IDH1 leads to the decrease of oxoglutaric acid levels compared with control group. |
Transcription factor (TF) |
Myc proto-oncogene protein (MYC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[15] |
Introduced Variation |
Knockdown (siRNA) of MYC |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colorectal cancer [ICD-11: 2B91]
|
Details |
It is reported that knockdown of MYC leads to the decrease of oxoglutaric acid levels compared with control group. |
Transferases (EC 2) |
Deacetylase sirtuin-5 (SIRT5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[16] |
Introduced Variation |
Knockout of Sirt5 |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Sirt5 leads to the decrease of oxoglutaric acid levels compared with control group. |
Isoprenylcysteine carboxylmethyltransferase (ICMT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[17] |
Introduced Variation |
Inhibition (Cysmethynil) of ICMT |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Breast cancer [ICD-11: 2C60]
... |
Details |
It is reported that inhibition of ICMT leads to the decrease of oxoglutaric acid levels compared with control group. |
Lipoyl synthase (LIAS) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Mutation (R249H) of LIAS |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
|
Details |
It is reported that mutation (R249H) of LIAS leads to the increase of oxoglutaric acid levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Knockout of LIAS |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
|
Details |
It is reported that knockout of LIAS leads to the increase of oxoglutaric acid levels compared with control group. |
Pyridoxal kinase (PDXK) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[18] |
Introduced Variation |
Knockout (CRISPR/Cas9 sgRNA) of Pdxk |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Acute myeloid leukaemia [ICD-11: 2A60]
|
Details |
It is reported that knockout of Pdxk leads to the decrease of oxoglutaric acid levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[18] |
Introduced Variation |
Knockout (CRISPR/Cas9 sgRNA) of PDXK |
Induced Change |
Oxoglutaric acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Acute myeloid leukaemia [ICD-11: 2A60]
|
Details |
It is reported that knockout of PDXK leads to the decrease of oxoglutaric acid levels compared with control group. |
Transaldolase (TALDO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[19] |
Introduced Variation |
Knockout of Taldo1 |
Induced Change |
Oxoglutaric acid concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Taldo1 leads to the increase of oxoglutaric acid levels compared with control group. |
|
|
|
|
|
|
|